Tamar Polonsky to Aged, 80 and over
This is a "connection" page, showing publications Tamar Polonsky has written about Aged, 80 and over.
Connection Strength
0.427
-
Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease. J Vasc Surg. 2024 Apr; 79(4):893-903.
Score: 0.095
-
Associations of Weight Change With Changes in Calf Muscle Characteristics and Functional Decline in Peripheral Artery Disease. J Am Heart Assoc. 2019 07 02; 8(13):e010890.
Score: 0.070
-
Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Mar 20; 6(3).
Score: 0.060
-
The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease. Vasc Med. 2024 12; 29(6):640-652.
Score: 0.025
-
Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2024 Jun 03; 31(8):1048-1054.
Score: 0.025
-
High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study. Menopause. 2021 01 04; 28(3):284-291.
Score: 0.019
-
Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease. Vasc Med. 2020 08; 25(4):319-327.
Score: 0.019
-
Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial. Circ Res. 2020 02 28; 126(5):589-599.
Score: 0.018
-
Femoral artery plaque characteristics, lower extremity collaterals, and mobility loss in peripheral artery disease. Vasc Med. 2017 12; 22(6):473-481.
Score: 0.016
-
Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial. JAMA Cardiol. 2017 08 01; 2(8):902-907.
Score: 0.015
-
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
Score: 0.015
-
Racial differences in functional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017 09; 66(3):826-834.
Score: 0.015
-
Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol. 2016 Jan 19; 67(2):139-147.
Score: 0.014
-
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circulation. 2015 Sep 08; 132(10):916-22.
Score: 0.013
-
Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest. 2007 Apr; 131(4):964-71.
Score: 0.007